Optogenetics Market - Growth, Trends, and Forecasts (2020 - 2025)
The Optogenetics Market is segmented By Light Equipment (Laser and Light-emitting Diode), By Actuator, By Sensor, By Application, and Geography.
ABOUT THIS REPORT
Scope of the Report
Key Market Trends
TABLE OF CONTENTS
Fastest Growing Market:
Need a report that reflects how COVID-19 has impacted this market and its growth?
The optogenetics market is expected to register a CAGR of nearly 16.5% during the forecast period. The major factors driving the growth of the market include the scope of optogenetics as a potential diagnostic tool in the field of neurosciences, rapid growth of advanced technologies, and the increasing use of multimodal imaging.
Optogenetics is a new research method that has revolutionized neuroscience over the last few years and opened up new possibilities to develop a deeper understanding of the function of human brain.
It allows researchers to study how the neurological activity patterns within specific brain cells give rise to thoughts, behaviors, and memories at an unprecedented precision level. Thus, it helps to find cures and treatments for neurological and psychiatric disorders, such as depression, addiction, schizophrenia, and Parkinson's disease.
As per Parkinsons Foundation survey report, approximately 60,000 Americans are diagnosed with parkinsons disease each year. Moreover, about 10 million people worldwide suffered with parkinsons disease in 2016.
Researchers are now moving forward with concrete plans to treat neurological diseases by developing collaborations with pharmaceutical companies to help them use optogenetics in animal research, in order to develop novel drug targets for diseases in humans.
Improvement and technological advancements in toolsets, such as neural connectivity, cell phenotyping tools, neural recording, and imaging tools, have further enhanced and helped the growth of the optogenetics market in neuroscience.
The advantage of optogenetics over other neuromodulation techniques is its high-temporal specificity, combined with cellular precision. Thus, increasing research in neuroscience and brain studies has helped in fueling the growth of the optogenetics market.
Scope of the Report
As per the scope of this report, optogenetics refers to a range of optical techniques, used to elicit a physiological response in targeted biological systems, in the absence of pharmacology and electric stimulations. Optogenetics controls the neural activity by combining genetic engineering and optical tools, and is widely used in neuroscience for the modulation of neural circuits with a high degree of precision and specificity. The optogenetics market is segmented by light equipment, actuator, sensor, application, and geography.
By Light Equipment
Light-emitting Diode (LED)
Calcium (Aequorin, Cameleon, and Other Calcium Sensors)
Retinal Disease Treatment
Rest of Europe
Rest of Asia-Pacific
Middle-East and Africa
Rest of Middle-East & Africa
Rest of South America
Report scope can be customized per your requirements. Click here.
Key Market Trends
Light-emitting Diode (LED) Segment is Expected to Hold a Major Market Share in the Optogenetics Market
LEDs are found to surpass lasers in every aspect, as they are cheaper, smaller, more reliable, and easier to control. They are being incorporated into implants, allowing untethered light delivery. However, the major drawback, and the reason that they have not been as widely adopted in the field of optogenetics is due to the difficulty in coupling the light with a fiber optic cable, with high efficiency.
Although individual LEDs can emit as much as five watts of light, the light is emitted in all directions, rather than in a coherent beam. These are among the major factors that are restricting the growth of the segment in the market.
However, a recent class of fiber-coupled LEDs offers much higher intensities of fiber-coupled light. Hence, there are many advancements, in both LED technologies and their applications. Effective LED therapies are used in treating cutaneous and neurological diseases. The researchers in LEDs, imaging, light therapy, and optogenetics have understood the basic principles, and hence, they are stimulating the applications of LEDs in healthcare. Thus, owing to above factors the segment is expected to grow in coming years.
To understand key trends, Download Sample Report
North America is Expected to Dominate the Market
North America is expected to lead the market, owing to the increase in use of optogenetic devices, primarily in academic and research labs.
According to the Parkinson's Foundation, approximately 1.2 million people in the United States are estimated to suffer from parkinsons disease by 2030.
Currently, the most common application of optogenetics is with live animals. Additionally, it is rapidly being used in various academic and research labs across the United States, which helps in driving the market, globally.
Many advancements in neuroscience are made possible by the BRAIN initiative (Brain Research through Advancing Innovative Neurotechnologies), which is a massive, collaborative, private-public funded project aimed at gaining a better understanding of the human brain.
In 2014, the US federal budget committed USD 100 million to the BRAIN initiative, and has been increased the funding by USD 100 million each year, since 2014. Such initiatives may open new doors that may boost the US optogenetics market.
In 2016, the RetroSense Therapeutics completed the low-dose cohort in the clinical trial of novel gene therapy application of optogenetics. Hence, all the aforementioned factors have helped in the growth of the market.
To understand geography trends, Download Sample Report.
The optogenetics Market is moderately consolidated, owing to the presence of various small and large players. Some of the market players are Addgene, Cobolt Inc., Coherent Inc., Gensight Biologics, Laserglow Technologies, Noldus Information Technology, Scientifica, Shanghai Laser & Optics Century Co. Ltd, and Thorlabs Inc.